Comerica Bank
TRVI icon

Comerica Bank’s Trevi Therapeutics TRVI Stock Holding History

Comerica Bank’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.04M Buy
83,027
+82,603
+19,482% +$955K ﹤0.01% 1487
2025
Q3 		$3.88K Sell
424
-211
-33% -$1.58K ﹤0.01% 3442
2025
Q2 		$3.47K Buy
+635
New +$3.95K ﹤0.01% 3426

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Comerica Bank's TRVI Position: Q4 2025 in Review

Comerica Bank increased its Trevi Therapeutics (TRVI) stake by 19,482% in Q4 2025, buying an estimated $955K and bringing the position to 83,027 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

Comerica Bank first reported a position in TRVI in Q2 2025 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold TRVI as of Q4 2025.

  • Comerica Bank held 83,027 shares of Trevi Therapeutics worth $1.04M as of Q4 2025.
  • Comerica Bank bought 82,603 Trevi Therapeutics shares in Q4 2025, an estimated $955K.
  • Trevi Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1487 holding.
  • Comerica Bank first reported a position in Trevi Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 184 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.